HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shanta Bhattarai Selected Research

(ortho-nitrophenyl)sulfenyl pentagastrin

11/2021CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shanta Bhattarai Research Topics

Disease

3Neoplasms (Cancer)
11/2021 - 07/2015
1Breast Neoplasms (Breast Cancer)
11/2021
1Triple Negative Breast Neoplasms
11/2021
1Prostatic Neoplasms (Prostate Cancer)
07/2015

Drug/Important Bio-Agent (IBA)

3GoldIBA
11/2021 - 07/2015
1(ortho-nitrophenyl)sulfenyl pentagastrinIBA
11/2021
1CXCR4 Receptors (CXCR4 Receptor)IBA
11/2021
1LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
07/2015
1Goserelin (Zoladex)FDA Link
07/2015
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
07/2015

Therapy/Procedure

3Radiotherapy
11/2021 - 07/2015